Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Regulatory News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
11.50    0.00 (0.00%)
Bid:
11.00
Ask:
12.00
Spread: 1.00 (9.091%)
Market Cap: £14.39m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Site Update

11 Nov 2008 07:00

RNS Number : 8653H
Fabian Romania Limited
11 November 2008
 

Fabian Romania Limited ("Fabian Romania" or the "Company")

Fabian Romania achieves Building Permit for "The Orchard" residential development site in Timisoara.

Fabian Romania along with its development partner Coltex Construct has been granted the building permit for its residential development scheme of 429 apartments in Timisoara.

The Orchard will provide 429 high quality apartments constructed in two phases, totalling 38,812 sqm with an additional 540 car spaces. 

Designed by international architects, Jestico Whiles, the Directors of Fabian Romania believe that it will provide a new degree of quality residential product not seen before in the local market. The site is located 10 minutes to the north west of Timisoara city centre in a residential neighbourhood with good access just off Strada Textilistolor, one of the main routes travelling north out of the city. 

Timisoara is built on the site of an historical Roman fortress. Over the years it has been influenced by many cultures and is now an important university city with strong links to its industrial heritage. The population has expanded rapidly over the last 10 years to over 300,000. International companies have invested in the city including Continental, Nestle and Procter & Gamble. As the wealth of the city has grown this has created demand for residential development.

Commenting on the transaction, Mark Owen, Property Director of Fabian Capital, the Company's Investment Manager said: 

"This has been a phased land acquisition and we are pleased to have achieved all the permits necessary to start construction. The scheme is an excellent design and well located just north of the city and close to existing retail shopping malls. In light of current market conditions we have secured the value of the site by obtaining these permits and will assess market conditions early next year and establish when the time is right for construction to commence."

Enquiries

 

Fabian Capital:

Anthony Foster +44 20 7499 9988

 

Deloitte Corporate Finance - Nominated Adviser to Fabian Romania

 

Mike Bell +44 20 7007 1463

 

Shore Capital Stockbrokers Limited - Joint Broker to Fabian Romania

 

Dru Danford +44 20 7408 2090

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXFEFLFPFFE
Date   Source Headline
20th Nov 20207:00 amRNSHalf-year Report
17th Nov 20202:00 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSNotice of Results
28th Oct 20204:41 pmRNSSecond Price Monitoring Extn
28th Oct 20204:36 pmRNSPrice Monitoring Extension
27th Oct 20207:00 amRNSReceipt of grants from Invest Northern Ireland
25th Sep 202011:38 amRNSResult of AGM
24th Sep 20202:39 pmRNSDirector/PDMR Shareholding
22nd Sep 20205:16 pmRNSHolding(s) in Company
18th Sep 20209:31 amRNSUpdate on R&D programme
28th Aug 20207:00 amRNSNotice of AGM
19th Aug 20207:00 amRNSFinal Results
11th Aug 20209:33 amRNSQueens University Belfast funding
31st Jul 20205:00 pmRNSTotal Voting Rights
7th Jul 20202:12 pmRNSExercise of Options
6th Jul 20204:41 pmRNSSecond Price Monitoring Extn
6th Jul 20204:36 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSTrading update
4th Jun 202012:57 pmRNSHolding(s) in Company
29th May 20205:00 pmRNSTotal Voting Rights
21st May 20206:24 pmRNSHolding(s) in Company
21st May 20202:52 pmRNSHolding(s) in Company
15th May 20204:49 pmRNSHolding(s) in Company
15th May 202010:47 amRNSResult of General Meeting & Total Voting Rights
15th May 20208:30 amRNSHolding(s) in Company
28th Apr 20207:00 amRNSPlacing to raise £3m, trading update, notice of GM
17th Apr 20204:41 pmRNSSecond Price Monitoring Extn
17th Apr 20204:35 pmRNSPrice Monitoring Extension
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:36 pmRNSPrice Monitoring Extension
16th Apr 20203:51 pmRNSResearch Alliance with Queen’s University Belfast
16th Apr 20202:06 pmRNSSecond Price Monitoring Extn
16th Apr 20202:01 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSTrading update
19th Mar 20207:00 amRNSBelfast investor presentation
17th Mar 20207:00 amRNSDirector/PDMR Shareholding
17th Feb 20207:00 amRNSBelfast investor presentation
3rd Feb 202012:01 pmRNSDirector/PDMR Shareholding
30th Jan 20204:40 pmRNSSecond Price Monitoring Extn
30th Jan 20204:35 pmRNSPrice Monitoring Extension
29th Jan 20207:00 amRNSTrading update
10th Jan 202011:47 amRNSDirector/PDMR Shareholding
3rd Dec 20199:26 amRNSDirector/PDMR Shareholding
2nd Dec 20197:00 amRNSHalf-year Report
26th Nov 201911:13 amRNSNotice of Results
22nd Oct 20197:00 amRNSHalf year trading update
26th Sep 20199:54 amRNSDirector/PDMR Shareholding
20th Sep 20192:14 pmRNSResult of AGM
21st Aug 20197:00 amRNSPosting of Annual Report & Notice of AGM
3rd Jul 20194:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.